DSIP (delta sleep-inducing peptide)
Cognitive · Neuropeptide
Tier C+
Bottom line
Read Off Label grades DSIP (delta sleep-inducing peptide) as C+ (5.7/10) based on weak evidence, variable benefit magnitude, and a low-risk safety profile.
First characterized Monnier 1977.
Typical use: 100-500 mcg subQ at night (anecdotal) — Research peptide.
What this is
First characterized Monnier 1977. Despite the name, not reliably sleep-inducing in controlled studies. Popular in peptide community for sleep/recovery; evidence is thin. Short plasma half-life.
Mechanism
Nonapeptide isolated from rabbit brain dialysate during delta sleep; proposed sleep modulatory and stress-protective effects; mechanism unclear
Dose & route
100-500 mcg subQ at night (anecdotal)
Citations
- https://pubmed.ncbi.nlm.nih.gov/6392441/
- https://pubmed.ncbi.nlm.nih.gov/3797927/
- https://pubmed.ncbi.nlm.nih.gov/2657552/
Links go to the source. If a link is dead or you want something re-checked, let me know.
Common questions
- Does DSIP (delta sleep-inducing peptide) work?
- Read Off Label rates the evidence for DSIP (delta sleep-inducing peptide) as Weak and the benefit magnitude as variable, producing an overall grade of C+ (5.7/10). First characterized Monnier 1977.
- Is DSIP (delta sleep-inducing peptide) safe?
- DSIP (delta sleep-inducing peptide) has a low risk profile in published human data. Legal status: Research peptide. This is not medical advice — see the disclaimer.
- What is the typical dose for DSIP (delta sleep-inducing peptide)?
- 100-500 mcg subQ at night (anecdotal)
- How does DSIP (delta sleep-inducing peptide) work?
- Nonapeptide isolated from rabbit brain dialysate during delta sleep; proposed sleep modulatory and stress-protective effects; mechanism unclear
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.